Neoadjuvant chemotherapy followed by post-partum chemoradiotherapy and chemoconsolidation for stage IIIB glassy cell cervical carcinoma during pregnancy
“…In 78.6% of women in the case group (33/42), a diagnosis of squamous cell carcinoma was established, [11][12][13][14][15][16][17]19,[21][22][23][24][25][26][27]29,31,34 whereas in 14.3% of women in the case group (6/42), adenocarcinoma was diagnosed 11,14,15,18,19,34 ; additionally, one woman each in the case groups of clear cell, of small cell, and of glossy cell carcinoma was identified. 17,20,30 The stage at diagnosis during pregnancy was early (stages I and II) in 93.5% of women in the case group and advanced in 6.5% of women in the case group. The mean gestational age at cervical cancer diagnosis was 19.5 weeks (SD 4.7, median 20 weeks, range 8-29 weeks), whereas the mean gestational age at chemotherapy administration was 23.9 weeks (SD 4.2, median 24 weeks, range 17-33 weeks).…”
Section: Resultsmentioning
confidence: 96%
“…The administration of platinum derivatives resulted in 97.9% of women in the case group (47/48) in the birth of live neonates [11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][32][33][34] and in 2.1% of women in the case group (1/48) in miscarriage. 31 In relation to cisplatin, 47 pregnancies (47 newborns) were identified ; regarding carboplatin administration, only one pregnancy (one newborn) was retrieved.…”
Section: Resultsmentioning
confidence: 99%
“…31 In relation to cisplatin, 47 pregnancies (47 newborns) were identified ; regarding carboplatin administration, only one pregnancy (one newborn) was retrieved. 17 Specifically, cisplatin was administered either as monotherapy 11,[14][15][16][18][19][20][21][22]24,25,27,[31][32][33][34] or combined with bleomycin, 26 5-fluorouracil, 33 paclitaxel, 11,12,17 vincristine, 11,13,23,[29][30][31][32] or vincristine and bleomycin 28 ; carboplatin was given in combination with paclitaxel. 17 The mean age of patients with cervical cancer at diagnosis was 32.5 years (standard deviation [SD] 4.3, median 32.5 years, range 25-42 years).…”
“…In 78.6% of women in the case group (33/42), a diagnosis of squamous cell carcinoma was established, [11][12][13][14][15][16][17]19,[21][22][23][24][25][26][27]29,31,34 whereas in 14.3% of women in the case group (6/42), adenocarcinoma was diagnosed 11,14,15,18,19,34 ; additionally, one woman each in the case groups of clear cell, of small cell, and of glossy cell carcinoma was identified. 17,20,30 The stage at diagnosis during pregnancy was early (stages I and II) in 93.5% of women in the case group and advanced in 6.5% of women in the case group. The mean gestational age at cervical cancer diagnosis was 19.5 weeks (SD 4.7, median 20 weeks, range 8-29 weeks), whereas the mean gestational age at chemotherapy administration was 23.9 weeks (SD 4.2, median 24 weeks, range 17-33 weeks).…”
Section: Resultsmentioning
confidence: 96%
“…The administration of platinum derivatives resulted in 97.9% of women in the case group (47/48) in the birth of live neonates [11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][32][33][34] and in 2.1% of women in the case group (1/48) in miscarriage. 31 In relation to cisplatin, 47 pregnancies (47 newborns) were identified ; regarding carboplatin administration, only one pregnancy (one newborn) was retrieved.…”
Section: Resultsmentioning
confidence: 99%
“…31 In relation to cisplatin, 47 pregnancies (47 newborns) were identified ; regarding carboplatin administration, only one pregnancy (one newborn) was retrieved. 17 Specifically, cisplatin was administered either as monotherapy 11,[14][15][16][18][19][20][21][22]24,25,27,[31][32][33][34] or combined with bleomycin, 26 5-fluorouracil, 33 paclitaxel, 11,12,17 vincristine, 11,13,23,[29][30][31][32] or vincristine and bleomycin 28 ; carboplatin was given in combination with paclitaxel. 17 The mean age of patients with cervical cancer at diagnosis was 32.5 years (standard deviation [SD] 4.3, median 32.5 years, range 25-42 years).…”
“…20,21 Some authors have made an association between this tumor and pregnancy; however, others did not find any association between them. 20,21 Some authors have made an association between this tumor and pregnancy; however, others did not find any association between them.…”
Section: Case Reportmentioning
confidence: 98%
“…20,21 Some authors have made an association between this tumor and pregnancy; however, others did not find any association between them. 20 The prognosis of patients with glassy cell carcinoma is considered to be poor because of its rapid progression, its frequent distant metastasis, and its relative resistance to conventional treatment modalities (surgery, radiotherapy, and chemotherapy). 20 The prognosis of patients with glassy cell carcinoma is considered to be poor because of its rapid progression, its frequent distant metastasis, and its relative resistance to conventional treatment modalities (surgery, radiotherapy, and chemotherapy).…”
The implantation of neoplastic cells in the perineum is a potential risk of vaginal delivery, with a 40% mortality rate. It thus seems advisable to avoid vaginal delivery as much as possible when cervical cancer is diagnosed during pregnancy. Given the rarity, there are no studies on the most effective treatment in such situations.
Systematic ascertainment of women early in pregnancy, preferably in a population base, is needed for assessment of true risks. Long-term follow-up is needed to rule out neurobehavioral effects.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.